INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

724 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
54
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$17.44M
26.8K sh
Nov 10, 2025Nov 13, 2025
Page 18 of 19
← PrevNext →
traded Nov 10, 2025
+3d
SEC Form 4

Evidence

53
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$1.79M
38.9K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$2.81M
4,367 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$235K
5,000 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$1.43M
2,201 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$1.76M
2,684 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$6.14M
9,392 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$1.55M
2,399 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$1.42M
2,194 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
KD
Karydas DaphneDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$226K
4,885 sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$6.24M
9,619 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

50
GP
Gu PaulDirector, Chief Technology Offier
UPSTUpstart Holdings, Inc.
Open-market purchase
BUY$3.14M
80.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

50
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$593K
12.7K sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

65
FS
Forste Adam Matthew SchwartzDirector, Co-Executive Chairman, 10% Owner
LINELineage, Inc.
Open-market purchase
BUY$2.50M
74.0K sh
Nov 10, 2025Nov 12, 2025
traded Nov 10, 2025
+2dSEC Form 4

Evidence

60
LU
LSP 7 Cooperative UA10% Owner
EVMNEvommune, Inc.
Open-market purchase
BUY$25.00M
1.56M sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC Form 4

Evidence

60
VI
Verduyn-van Weegen Felice IsabelDirector, 10% Owner
EVMNEvommune, Inc.
Open-market purchase
BUY$25.00M
1.56M sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC Form 4

Evidence

56
FA
Ford William ACHIEF OPERATING OFFICER
WESTWestrock Coffee Co
Open-market purchase
BUY$35K
7,950 sh
Nov 11, 2025Nov 12, 2025
traded Nov 11, 2025
+1dSEC Form 4

Evidence

56
FA
Ford William ACHIEF OPERATING OFFICER
WESTWestrock Coffee Co
Open-market purchase
BUY$18K
3,925 sh
Nov 11, 2025Nov 12, 2025
traded Nov 11, 2025
+1dSEC Form 4

Evidence

56
FA
Ford William ACHIEF OPERATING OFFICER
WESTWestrock Coffee Co
Open-market purchase
BUY$19K
4,436 sh
Nov 11, 2025Nov 12, 2025
traded Nov 11, 2025
+1dSEC Form 4

Evidence

54
MP
Marchetti Kevin PatrickDirector, Co-Executive Chairman, 10% Owner
LINELineage, Inc.
Open-market purchase
BUY$489K
14.5K sh
Nov 10, 2025Nov 12, 2025
traded Nov 10, 2025
+2dSEC Form 4

Evidence

52
CC
Christel Eric CEVP, Chief Financial Officer
BLMNBloomin' Brands, Inc.
Open-market purchase
BUY$957K
150.0K sh
Nov 10, 2025Nov 12, 2025
traded Nov 10, 2025
+2dSEC Form 4

Evidence

52
Neman JonathanDirector, CHIEF EXECUTIVE OFFICER
SGSweetgreen, Inc.
Open-market purchase
BUY$1000K
179.8K sh
Nov 12, 2025Nov 12, 2025
traded Nov 12, 2025
+0dSEC Form 4

Evidence

51
WP
Warburg Pincus & Co.Director, 10% Owner
SHCSotera Health Co
Open-market sale
SELL$281.72M
18.00M sh
Nov 10, 2025Nov 12, 2025
traded Nov 10, 2025
+2dSEC Form 4

Evidence

51
WP
Warburg Pincus & Co.Director, 10% Owner
SHCSotera Health Co
Open-market sale
SELL$281.72M
18.00M sh
Nov 10, 2025Nov 12, 2025
traded Nov 10, 2025
+2dSEC Form 4

Evidence

51
GR
Gray Nancy RyanDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$731K
3,556 sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC Form 4

Evidence

51
GR
Gray Nancy RyanDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$619K
3,015 sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC Form 4

Evidence

60
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale
SELL$71.98M
559.5K sh
Nov 7, 2025Nov 10, 2025
traded Nov 7, 2025
+3dSEC Form 4

Evidence

60
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale
SELL$13.63M
105.0K sh
Nov 7, 2025Nov 10, 2025
traded Nov 7, 2025
+3dSEC Form 4

Evidence

59
RE
Rockwell EdwardSVP/General Counsel
EPAMEPAM Systems, Inc.
Open-market purchase
BUY$7,500
56 sh
Apr 30, 2025Nov 10, 2025
traded Apr 30, 2025
+194dSEC Form 4

Evidence

59
DV
Dvorkin ViktarSVP/Head of Global Delivery
EPAMEPAM Systems, Inc.
Open-market purchase
BUY$7,500
56 sh
Apr 30, 2025Nov 10, 2025
traded Apr 30, 2025
+194dSEC Form 4

Evidence

59
AC
Abrahams Gary CVP, Corporate Controller, PAO
EPAMEPAM Systems, Inc.
Open-market purchase
BUY$7,500
56 sh
Apr 30, 2025Nov 10, 2025
traded Apr 30, 2025
+194dSEC Form 4

Evidence

59
PD
Peterson Jason D.Chief Financial Officer
EPAMEPAM Systems, Inc.
Open-market purchase
BUY$7,500
56 sh
Apr 30, 2025Nov 10, 2025
traded Apr 30, 2025
+194dSEC Form 4

Evidence

57
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale
SELL$4.53M
34.7K sh
Nov 7, 2025Nov 10, 2025
traded Nov 7, 2025
+3dSEC Form 4

Evidence

56
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale
SELL$80.73M
630.9K sh
Nov 7, 2025Nov 10, 2025
traded Nov 7, 2025
+3dSEC Form 4

Evidence

54
CR
Crisci RobertChief Financial Officer
LINELineage, Inc.
Open-market purchase
BUY$346K
10.0K sh
Nov 7, 2025Nov 10, 2025
traded Nov 7, 2025
+3dSEC Form 4

Evidence

50
PD
Peterson Jason D.Chief Financial Officer
EPAMEPAM Systems, Inc.
Open-market purchase
BUY$7,500
56 sh
Oct 31, 2025Nov 10, 2025
traded Oct 31, 2025
+10dSEC Form 4

Evidence

50
AC
Abrahams Gary CVP, Corporate Controller, PAO
EPAMEPAM Systems, Inc.
Open-market purchase
BUY$7,500
56 sh
Oct 31, 2025Nov 10, 2025
traded Oct 31, 2025
+10dSEC Form 4

Evidence

50
RE
Rockwell EdwardSVP/General Counsel
EPAMEPAM Systems, Inc.
Open-market purchase
BUY$7,500
56 sh
Oct 31, 2025Nov 10, 2025
traded Oct 31, 2025
+10dSEC Form 4

Evidence

50
DV
Dvorkin ViktarSVP/Head of Global Delivery
EPAMEPAM Systems, Inc.
Open-market purchase
BUY$7,500
56 sh
Oct 31, 2025Nov 10, 2025
traded Oct 31, 2025
+10dSEC Form 4

Evidence

58
GC
Goldberg ChenSVP of Engineering
CRWVCoreWeave, Inc.
Open-market sale
SELL$2.27M
19.2K sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence